Sofinnova Investments, Inc.Firm match from fund name (lower confidence)
Sofinnova Venture Partners XII, L.P.
Raising: Form D filed Jun 2026 reports amount sold below target
- Vintage
- 2024
- Fund size
- $527.07M to $550M (Form D)
- Stages
- Not stated
- Sectors
- Biotech
- Regions
- Global
01 · Thesis
Sofinnova is a healthcare investment firm focused on life science investing, primarily therapeutics. It invests in late preclinical and clinical therapeutic companies across the U.S. and Europe, with key areas including oncology, respiratory, dermatology, ophthalmology, neurology and women's health.Inferred from the firm's website
02 · Initial check
$5.27M to $9.17M (estimated from fund size)
Estimated from Form D: $527.07M sold of a $550M target
03 · Who to approach
Named on this fund's Form D
- Maha Katabi, PhD, CFA, General Partner
- Jim Healy, MD, PhD, Managing Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideSofinnova is a healthcare investment firm focused on life science investing, primarily therapeutics, investing in late preclinical and clinical therapeutic companies across the U.S. and Europe.
Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.
https://www.sofinnova.com/about/
06 · Sources
Last verified: Oct 28, 2026